EKG — CardioComm Solutions Income Statement
0.000.00%
Last trade - 00:00
- CA$1.51m
- CA$1.90m
- CA$1.00m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.08 | 0.875 | 0.835 | 0.683 | 0.996 |
Cost of Revenue | |||||
Gross Profit | 0.687 | 0.627 | 0.682 | 0.611 | 0.727 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.68 | 1.82 | 0.98 | 0.948 | 1.07 |
Operating Profit | -0.604 | -0.944 | -0.146 | -0.266 | -0.077 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.577 | -1.06 | -0.064 | 0 | -0.002 |
Net Income After Taxes | -0.577 | -1.06 | -0.064 | 0 | -0.002 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.577 | -1.06 | -0.064 | 0 | -0.002 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.577 | -1.06 | -0.064 | 0 | -0.002 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.004 | -0.008 | -0 | 0 | -0 |